Scandicane
Scandicane Brand names, Scandicane Analogs
Scandicane Brand Names Mixture
- No information avaliable
Scandicane Chemical_Formula
C4H11N5
Scandicane RX_link
http://www.rxlist.com/cgi/generic4/glumetza.htm
Scandicane fda sheet
Scandicane msds (material safety sheet)
Scandicane Synthesis Reference
No information avaliable
Scandicane Molecular Weight
129.164 g/mol
Scandicane Melting Point
223-226 oC
Scandicane H2O Solubility
Freely soluble as HCl salt
Scandicane State
Solid
Scandicane LogP
-0.267
Scandicane Dosage Forms
Extended release tablet (500 mg or 1000 mg)
Scandicane Indication
For use as an adjunct to diet and exercise to improve glycemic control in adult patients (18 years and older) with type 2 diabetes.
Scandicane Pharmacology
Metformin is an antihyperglycemic agent, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Metformin is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Unlike sulfonylureas, metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal subjects and does not cause hyperinsulinemia. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and daylong plasma insulin response may actually decrease.
Scandicane Absorption
Absorbed over 6 hours, bioavailability is 50 to 60% under fasting conditions. Food delays absorption.
Scandicane side effects and Toxicity
Acute oral toxicity (LD50): 350 mg/kg [Rabbit]. It would be expected that adverse reactions of a more intense character including epigastric discomfort, nausea, and vomiting followed by diarrhea, drowsiness, weakness, dizziness, malaise and headache might be seen.
Scandicane Patient Information
Scandicane Organisms Affected
Humans and other mammals
